Potent inhibitors of Huntingtin protein aggregation in a cell-based assay

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1715-7. doi: 10.1016/j.bmcl.2009.01.087. Epub 2009 Jan 30.

Abstract

A quinazoline that decreases polyglutamine aggregate burden in a cell-based assay was identified from a high-throughput screen of a chemical-compound library, provided by the NIH Molecular Libraries Small Molecule Repository (MLSMR). A structure and activity study yielded leads with submicromolar potency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemistry, Pharmaceutical / methods*
  • Combinatorial Chemistry Techniques
  • Drug Design
  • Drug Discovery
  • Drug Evaluation, Preclinical
  • Humans
  • Huntingtin Protein
  • Inhibitory Concentration 50
  • Models, Chemical
  • Molecular Structure
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nuclear Proteins / antagonists & inhibitors*
  • Peptides / chemistry
  • Quinazolines / chemistry*
  • Structure-Activity Relationship

Substances

  • HTT protein, human
  • Huntingtin Protein
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Peptides
  • Quinazolines
  • polyglutamine